(Q45103257)

9 December 2017

title

Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy (English)

1 reference

9 December 2017

Dam M

1

1 reference

9 December 2017

publication date

1 January 1989

1 reference

9 December 2017

1 reference

9 December 2017

volume

30 Suppl 3

1 reference

9 December 2017

page(s)

S26-30

1 reference

Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

Vigabatrin in the treatment of epilepsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

Vigabatrin: no microvacuoles in a human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1989.TB05830.X

10.1111/J.1528-1157.1989.TB05830.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference